The mechanism of allosteric regulation of calcium-independent phospholipase A 2 by ATP and calmodulin binding to the ankyrin domain
Open Access
- 19 November 2024
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (48)
Abstract
Group VIA calcium-independent phospholipase A 2 (iPLA 2 ) is a member of the PLA 2 superfamily that exhibits calcium-independent activity in contrast to the other two major types, secreted phospholipase A 2 (sPLA 2 ) and cytosolic phospholipase A 2 (cPLA 2 ), which both require calcium for their enzymatic activity. Adenosine triphosphate (ATP) has been reported to allosterically activate iPLA 2 , and this has now been verified with a lipidomics-based mixed-micelle assay, but its mechanism of action has been unknown. Hydrogen/deuterium exchange mass spectrometry (HDX-MS) was employed to identify ATP interaction peptide regions located within the ankyrin repeat domain at which ATP interacts. Molecular dynamics simulations revealed the mechanism by which ATP binds to its site and the main residues that interact. Site-directed mutagenesis was used to verify the importance of these residues in the role of ATP in regulating iPLA 2 activity. Importantly, calcium was found to abolish the enhancing regulatory function of ATP and to promote the inhibitory activity by calmodulin. Given previous evidence that calcium does not bind directly to iPLA 2 , its effect appears to be indirect via association with ATP and/or calmodulin. Using HDX-MS, we found that calmodulin interacts with the N terminus peptide region of iPLA 2 consisting of residues 20 to 28. These two regulatory iPLA 2 sites open the road to the development of potential targets for therapeutic intervention.Keywords
This publication has 45 references indexed in Scilit:
- Molecular basis of unique specificity and regulation of group VIA calcium-independent phospholipase A2 (PNPLA9) and its role in neurodegenerative diseasesPharmacology & Therapeutics, 2023
- Novel deep intronic mutation in PLA2G6 causing early-onset Parkinson’s disease with brain iron accumulation through pseudo-exon activationneurogenetics, 2021
- Lipidomics-based assays coupled with computational approaches can identify novel phospholipase A2 inhibitorsAdvances in Biological Regulation, 2020
- Phospholipase A2 catalysis and lipid mediator lipidomicsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2019
- Review of four major distinct types of human phospholipase A2Advances in Biological Regulation, 2018
- PLA2G6-associated neurodegeneration (PLAN): Further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset diseaseMolecular Genetics and Metabolism, 2014
- The Ankyrin Repeats of TRPV1 Bind Multiple Ligands and Modulate Channel SensitivityNeuron, 2007
- Mitochondrial localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human cancer cells: Implication in apoptosis resistanceExperimental Cell Research, 2005
- Identification of a Ca2+/calmodulin‐binding domain within the carboxyl‐terminus of the angiotensin II (AT1A) receptorFEBS Letters, 1999
- Interfacial activation, lysophospholipase and transacylase activity of Group VI Ca2+-independent phospholipase A2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998